| Losartan superior to atenolol for isolated systolic HT: substudy of LIFE finds relative reduction in stroke, MI, mortality, and diabetes. (Reduced LV Hypertrophy).(hypertension ... An article from: Internal Medicine News | Digitalby Bruce Jancin (Author)
| List Price: | $5.95 | | | Available: | Available for download now |
| | Binding: | Digital | | Publisher: | International Medical News Group | | Page Count: | 3 Pages | | Publication Date: | October 15, 2002 |
|
EDITORIAL REVIEWS |
Product Description
This digital document is an article from Internal Medicine News, published by International Medical News Group on October 15, 2002. The length of the article is 620 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Losartan superior to atenolol for isolated systolic HT: substudy of LIFE finds relative reduction in stroke, MI, mortality, and diabetes. (Reduced LV Hypertrophy).(hypertension )(Losartan Intervention for End Point Reduction in Hypertension)(myocardial infarction)Author: Bruce JancinPublication: Internal Medicine News (Magazine/Journal)Date: October 15, 2002Publisher: International Medical News GroupVolume: 35 Issue: 20 Page: 1(2)Distributed by Thomson Gale |
|
